[1]
Yosef, B., Kaddar, N. and Boubou, A. 2023. Evaluation of the Effect of Dapagliflozin on CRP Levels in Type 2 Diabetes Patients. Jordan Journal of Pharmaceutical Sciences. 16, 2 (Jun. 2023), 313–321. DOI:https://doi.org/10.35516/jjps.v16i2.1331.